Literature DB >> 6849731

Rate of entrance of benzodiazepines into the brain determined by eye movement recording.

G Tedeschi, A T Smith, S Dhillon, A Richens.   

Abstract

1 Peak saccadic velocity of horizontal eye movements, saccade duration at 30 degrees of amplitude and saccade reaction time were measured in six drug free male subjects. 2 In two separate experiments, intravenous doses of diazepam (5 mg), lorazepam (2 mg), chlordiazepoxide (25 mg) and placebo were given, and eye movement recordings were made before and at frequent intervals after drug administration. 3 All the benzodiazepines produced a significant impairment of peak saccadic velocity and saccade duration. Only lorazepam significantly affected saccade reaction time. 4 Time to achieve maximum effect was 10 min after diazepam, 29 min after lorazepam and 42 min after chlordiazepoxide.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849731      PMCID: PMC1427835          DOI: 10.1111/j.1365-2125.1983.tb01471.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Acute effects of alcohol on saccadic eye movements.

Authors:  I Lehtinen; A H Lang; V Jäntti; E Keskinen
Journal:  Psychopharmacology (Berl)       Date:  1979-05-08       Impact factor: 4.530

2.  The saccade velocity test.

Authors:  R W Baloh; H R Konrad; A W Sills; V Honrubia
Journal:  Neurology       Date:  1975-11       Impact factor: 9.910

3.  Kinetics of intravenous chlordiazepoxide: sex differences in drug distribution.

Authors:  D J Greenblatt; R I Shader; K Franke; D S MacLaughlin; B J Ransil; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

4.  Diazepam and lorazepam for intravenous surgical premedication.

Authors:  J T Conner; R L Katz; J W Bellville; C Graham; R Pagano; F Dorey
Journal:  J Clin Pharmacol       Date:  1978 May-Jun       Impact factor: 3.126

5.  The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.

Authors:  P R Bittencourt; P Wade; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

6.  Participation of medial pontine reticular formation in eye movement generation in monkey.

Authors:  E L Keller
Journal:  J Neurophysiol       Date:  1974-03       Impact factor: 2.714

7.  Brain uptake of phenytoin, phenobarbital, and diazepam.

Authors:  R E Ramsay; E J Hammond; R J Perchalski; B J Wilder
Journal:  Arch Neurol       Date:  1979-09

8.  Oral premedication with lorazepam (Ativan): a comparison with heptabarbitone (Medomin) and diazepam (Valium).

Authors:  J Wilson; F R Ellis
Journal:  Br J Anaesth       Date:  1973-07       Impact factor: 9.166

9.  Effect of alcohol and marijuana on eye movements.

Authors:  R W Baloh; S Sharma; H Moskowitz; R Griffith
Journal:  Aviat Space Environ Med       Date:  1979-01

10.  Subclinical eye movement disorders in patients with multiple sclerosis.

Authors:  L D Solingen; R W Baloh; L Myers; G Ellison
Journal:  Neurology       Date:  1977-07       Impact factor: 9.910

View more
  14 in total

1.  Objective and subjective assessments of the effects of flupentixol and benzodiazepines on human psychomotor performance.

Authors:  M J Mattila; M Mattila; K Aranko
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance.

Authors:  A N Griffiths; R W Marshall; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

3.  Saccadic eye movements analysis as a measure of drug effect on central nervous system function.

Authors:  G Tedeschi; A Quattrone; V Bonavita
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 4.  Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

5.  Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state.

Authors:  A L van Steveninck; R Gieschke; H C Schoemaker; M S Pieters; J M Kroon; D D Breimer; A F Cohen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses.

Authors:  K Aranko; T Seppälä; J Pellinen; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Benzodiazepine pharmacodynamics: utility of eye movement measures.

Authors:  P P Roy-Byrne; D S Cowley; A Radant; D Hommer; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration.

Authors:  R B Smith; P D Kroboth; J T Vanderlugt; J P Phillips; R P Juhl
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.

Authors:  A F Cohen; L Ashby; D Crowley; G Land; A W Peck; A A Miller
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

10.  Effects of oxazepam on eye movements and performance in vigilance tasks with static and dynamic stimuli.

Authors:  T H van Leeuwen; M N Verbaten; H S Koelega; G Camfferman; J van der Gugten; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.